 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 1 | 1/1 | 返回列表 |
| 查看: 605 | 回復(fù): 0 | |||
南北云金蟲 (小有名氣)
|
[交流]
香港科技大學(xué)高等研究院招聘雙特異性抗體研發(fā)博士后
|
|
香港科技大學(xué)高等研究院Jockey Club Institute for Advanced Study/ Division of Life Science招聘雙特異性抗體研發(fā)博士后 申請人需要具有 （1）生物化學(xué)/生物科學(xué)或相關(guān)學(xué)科的博士學(xué)位； （2）在以下領(lǐng)域之一中具有豐富的經(jīng)驗或背景：細(xì)胞生物學(xué)，細(xì)胞信號傳導(dǎo)和/或蛋白質(zhì)科學(xué)； （3）在哺乳動物細(xì)胞培養(yǎng)，開發(fā)和執(zhí)行基于細(xì)胞的功能測定，高通量篩選（例如ELISA）和/或蛋白質(zhì)純化和分析方面的豐富經(jīng)驗。使用FlowJo在流式細(xì)胞儀和數(shù)據(jù)分析方面的經(jīng)驗將是一個優(yōu)勢。 （4）候選人必須擁有香港本地大學(xué)或世界排名前100大學(xué)的博士學(xué)位。請注意，這點非常重要，是必須的。因為候選人的薪金是香港政府指定的計劃中出的。這點是基本要求之一。認(rèn)可的世界大學(xué)排名包括Quacquarelli Symonds World University Rankings，上海交通大學(xué)世界大學(xué)學(xué)術(shù)排名或Times Higher Education World University Rankings。獲得的學(xué)位應(yīng)在科學(xué)，技術(shù)，工程和數(shù)學(xué)（stem）相關(guān)學(xué)科中。 起薪將與資歷和經(jīng)驗相稱。 附加福利包括年假，醫(yī)療和牙科福利。 如若申請，請參閱一下鏈接。 https://hrmsxprod.psft.ust.hk:8044/psp/hrmsxprod/EMPLOYEE/HRMS/c/HRS_HRAM.HRS_CE.GBL?Page=HRS_CE_JOB_DTL&Action=A&JobOpeningId=5435&SiteId=1000&PostingSeq=1 ================= English Version Job Posting Details Positions for Post-doctoral Fellows are available in the IAS HKUST - Scripps R&D Laboratory to conduct research projects in biomedical sciences. The IAS HKUST – Scripts R&D Laboratory is co-supervised by Prof. Paul Schimmel (The Scripps Research Institute; HKUST IAS Visiting Professor) and Prof. Mingjie Zhang (Kerry Holdings Professor of Science and Chair Professor of Life Science, HKUST). It aims to elucidate the molecular mechanisms by which extracellular signaling molecules that originate from the aminoacyl-tRNA synthetase (AARS) family use to modulate diverse biology, as well as to translate the discovery of novel biological pathways to develop innovative therapeutics with improved outcomes for patients. The appointees will work closely with aTyr Pharma (a US biotech with clinical-stage molecules based on the AARS-family) on projects leading to the development of new therapeutics, and have opportunities for publication in high-impact journals as well as for filing of US patents. A project has recently been initiated, partially funded by the Hong Kong Innovation and Technology Commission (ITC), for creation of an innovative bispecific antibody drug-discovery platform and implementation of this cutting-edge platform to rapidly generate therapeutic candidates selectively targeting extracellular receptors of AARS. More laboratory information is available in the website: https://ias.ust.hk/web/ias/eng/p ... tid=4&sid=6 Applicants should have (i) a PhD degree in biochemistry/biological sciences or a related discipline; (ii) strong experience or background in one of the following areas: cell biology, cell signaling, and/or protein science; and (iii) extensive experience in culture of mammalian cells, developing and performing cell-based functional assays, high-throughput screening (e.g. ELISA), and/or protein purification and analysis. Experience in flow cytometry and data analysis using FlowJo would be an advantage. (iv) The candidate must possess a doctoral degree from either a Hong Kong university or an institution are among the top 100 institutions for related subjects in the latest publication of world university ranking tables, including the Quacquarelli Symonds World University Rankings, Shanghai Jiao Tong University (Academic Ranking of World Universities) or Times Higher Education World University Rankings. The degree obtained should be in a science, technology, engineering and mathematics (STEM) related discipline. The successful candidates should be self-motivated, capable of working independently with minimal supervision, and attentive to details. They should also have excellent analytical and problem-solving skills as well as verbal and written communication skills. Immediate availability is highly preferred. (Duration: 1 year, renewable) Starting salary will be commensurate with qualifications and experience. Fringe benefits including annual leave, medical and dental benefits will be provided where applicable. To apply, please refer to the following link for details. https://hrmsxprod.psft.ust.hk:8044/psp/hrmsxprod/EMPLOYEE/HRMS/c/HRS_HRAM.HRS_CE.GBL?Page=HRS_CE_JOB_DTL&Action=A&JobOpeningId=5435&SiteId=1000&PostingSeq=1 |
回復(fù)此樓» 猜你喜歡
一志愿天津大學(xué)材料與化工275求調(diào)劑
已經(jīng)有22人回復(fù)
-
0703求調(diào)劑
已經(jīng)有5人回復(fù)
-
0857 資源與環(huán)境 285分
已經(jīng)有6人回復(fù)
-
材料工程,326分，求調(diào)劑
已經(jīng)有5人回復(fù)
-
301求調(diào)劑
已經(jīng)有5人回復(fù)
-
334求調(diào)劑
已經(jīng)有3人回復(fù)
-
材料與化工085600調(diào)劑求老師收留
已經(jīng)有5人回復(fù)
-
一志愿華科071000生物學(xué) 338求調(diào)劑
已經(jīng)有4人回復(fù)
-
290求調(diào)劑
已經(jīng)有4人回復(fù)
-
308求調(diào)劑
已經(jīng)有4人回復(fù)
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 南北云 的主題更新
| 1 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿中科大材料與化工。353分能調(diào)劑到哪？ +5 | MayUxw1 2026-03-08 | 7/350 |
|
|---|---|---|---|---|
|
|
[考研] 泣血叩求調(diào)劑恩，愿以丹心報師恩 +5 | Iuruoh 2026-03-11 | 5/250 |
|
|
|
[考研] 291分獸醫(yī)專碩 一志愿華中農(nóng) +3 | 種大大太陽 2026-03-05 | 3/150 |
|
|
|
[考研] 290求調(diào)劑 +3 | 柯淮然 2026-03-10 | 8/400 |
|
|
|
[考研] 420求調(diào)劑 +3 | 莫向外求11 2026-03-10 | 3/150 |
|
|
[考研] 307求調(diào)劑 +6 | 超級伊昂大王 2026-03-10 | 6/300 |
|
|
|
[考研] 298求調(diào)劑 +3 | Vv呀！ 2026-03-10 | 3/150 |
|
|
|
[考研] 材料與化工求調(diào)劑 +11 | 與冬清寧 2026-03-07 | 14/700 |
|
|
|
[考研] 家人們 調(diào)劑不迷路 看這里 +8 | likeihood 2026-03-09 | 13/650 |
|
|
|
[考研] 材料調(diào)劑 +4 | xxxcm 2026-03-08 | 7/350 |
|
|
|
[考研] 0817找調(diào)劑 +6 | kk扛 2026-03-08 | 6/300 |
|
|
|
[考研] 理學(xué)287分求調(diào)劑 +4 | 看看我. 2026-03-05 | 4/200 |
|
|
|
[考研] 求調(diào)劑 +3 | 拾柒12。 2026-03-08 | 3/150 |
|
|
|
[考研] 081700學(xué)碩一志愿北京化工大學(xué)數(shù)二英一過六級有競賽求調(diào)劑 +5 | galaxary 2026-03-07 | 7/350 |
|
|
|
[考研] 材料化工求調(diào)劑 +7 | 博斯特525 2026-03-06 | 8/400 |
|
|
|
[考研] 一志愿哈爾濱工業(yè)大學(xué)0856材料與化工，前三科206，總分283，求調(diào)劑 +7 | 26考研求調(diào)劑 2026-03-06 | 7/350 |
|
|
|
[考研] 求調(diào)劑推薦 +4 | 微辣不吃 2026-03-06 | 4/200 |
|
|
|
[考博] 2026申博自薦 六級440電催化方向 +4 | 櫻落成影花成雙 2026-03-05 | 4/200 |
|
|
|
[考研] 304求調(diào)劑 +3 | 曼殊2266 2026-03-04 | 3/150 |
|
|
|
[考研] 316求調(diào)劑 +3 | 林小星發(fā)大財 2026-03-04 | 3/150 |
|